Autopsy report · NCT01378754

Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia

“Loss of funding before enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Grace Shih, MD

Sponsor type

University, hospital or other

Conditions

Interstitial Cystitis

Interventions

Fospropofol (Lusedra®) 6.5; Fospropofol (Lusedra®) 10; Fospropofol (Lusedra®) 12

Participants

0

Trials that died the same way

• Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury
  “low enrollment and loss of funding” (90% match in meaning)
• Brain Ion Homeostasis, Lithium and Bipolar Disorder
  “Lost funding due to low enrollment” (85% match in meaning)
• Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation
  “low enrollment, termination of funding” (85% match in meaning)
• Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
  “Funding ended before enrollment” (83% match in meaning)
• ALgorithms Adapted From Remote Monitoring
  “Low enrollment, completion of funding” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.